Massachusetts Financial Services CO Dexcom Inc Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Dexcom Inc stock. As of the latest transaction made, Massachusetts Financial Services CO holds 1,430,964 shares of DXCM stock, worth $115 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,430,964

Previous 2,439,033 41.33%

Holding current value

$115 Million

Previous $277 Million 65.32%

% of portfolio

0.03%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$64.0 - $116.06 $64.5 Million - $117 Million	-1,008,069 Reduced 41.33%	1,430,964 $95.9 Million
Q2 2024 Aug 09, 2024	BUY	$110.31 - $140.45 $38.9 Million - $49.6 Million	353,019 Added 16.92%	2,439,033 $277 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $24.9 Million - $30.6 Million	218,229 Added 11.68%	2,086,014 $289 Million
Q4 2023 Feb 08, 2024	BUY	$75.49 - $124.16 $141 Million - $232 Million	1,867,785 New	1,867,785 $232 Million
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $1.4 Million - $1.73 Million	-16,563 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $27 Million - $36.2 Million	-346,400 Reduced 95.44%	16,563 $6.12 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $2.72 Million - $3.21 Million	-28,450 Reduced 7.27%	362,963 $150 Million
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $5.09 Million - $8.56 Million	81,224 Added 26.19%	391,413 $159 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $3.78 Million - $5.98 Million	79,079 Added 34.22%	310,189 $83.5 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $1.12 Million - $1.75 Million	30,611 Added 15.27%	231,110 $50.6 Million
Q3 2019 Nov 05, 2019	BUY	$35.53 - $43.8 $588,661 - $725,678	16,568 Added 9.01%	200,499 $29.9 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $2.6 Million - $3.63 Million	-93,330 Reduced 33.66%	183,931 $27.6 Million
Q1 2019 May 13, 2019	BUY	$28.07 - $38.18 $1.15 Million - $1.56 Million	40,961 Added 17.33%	277,261 $33 Million
Q4 2018 Feb 08, 2019	BUY	$26.99 - $37.37 $1.07 Million - $1.49 Million	39,741 Added 20.22%	236,300 $28.3 Million
Q3 2018 Oct 25, 2018	SELL	$23.35 - $36.72 $421,841 - $663,383	-18,066 Reduced 8.42%	196,559 $28.1 Million
Q2 2018 Jul 30, 2018	SELL	$17.54 - $25.22 $3.31 Million - $4.76 Million	-188,911 Reduced 46.81%	214,625 $20.4 Million
Q1 2018 May 04, 2018	SELL	$13.06 - $18.54 $2.08 Million - $2.95 Million	-159,077 Reduced 28.27%	403,536 $29.9 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $167,634 - $231,853	15,075 Added 2.75%	562,613 $32.3 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $1.53 Million - $2.56 Million	135,022 Added 32.73%	547,538 $26.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	412,516	412,516 $30.2 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Dexcom Inc Transaction History